Latest Intelligence on R&D in Australia

Select information type

Refine your search

Search tips

Published within

« | 1 | » »|

Type Product title / description Pub Price

Roche/Genentech: Herceptin poised for an expanded role

Scientists have found that HER-2 is a key contributor to the development of pre-invasive breast cancer. Roche/Genentech's Herceptin, currently used to treat advanced breast cancer, can target HER-2. However, the detection of elevated HER-2 is not routine among most physicians. Despite this, Herceptin is well positioned to build its usage in early-stage and pre-cancerous populations.

Published By Datamonitor
14 Apr 2003

« | 1 | » »|

No help is available.